Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HAUS5 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | CTC1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | ZBTB5 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | BRSK1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | ZCCHC11 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | NTNG2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |